Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding: 2020-2022

Historic Shares Outstanding for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $45.8 million.

  • Cullinan Therapeutics' Shares Outstanding fell 6.52% to $42.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.8 million, marking a year-over-year decrease of 6.52%. This contributed to the annual value of $45.8 million for FY2022, which is 3.40% up from last year.
  • As of FY2022, Cullinan Therapeutics' Shares Outstanding stood at $45.8 million, which was up 3.40% from $44.3 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Shares Outstanding registered a high of $45.8 million during FY2022, and its lowest value of $29.8 million during FY2020.
  • For the 3-year period, Cullinan Therapeutics' Shares Outstanding averaged around $40.0 million, with its median value being $44.3 million (2021).
  • Data for Cullinan Therapeutics' Shares Outstanding shows a peak YoY skyrocketed of 48.48% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Cullinan Therapeutics' Shares Outstanding stood at $29.8 million in 2020, then skyrocketed by 48.48% to $44.3 million in 2021, then rose by 3.40% to $45.8 million in 2022.